Boeing shares are trading lower after the company's CEO presented at a Morgan Stanley conference mentioned that 777X testing may spill into next year and it is still waiting on the engine seal fix from GE Aerospace for final certification. The CFO said slower-than-expected 737 and 787 rate ramp-ups into the year-end reduces the likelihood of the company reaching the upper-end of its previous FCF forecast.

Boeing's stock is down due to delays in its key 777X program and slower production ramp-ups for the 737 and 787, impacting its free cash flow outlook. These issues signal ongoing operational challenges and regulatory hurdles for the aerospace giant.

This headline is a significant negative catalyst for Boeing, highlighting persistent operational and certification challenges. The 777X delay into next year and the reliance on GE Aerospace for a critical fix underscore regulatory scrutiny and supply chain vulnerabilities. Slower 737 and 787 ramp-ups directly impact revenue and profitability, leading to a reduced likelihood of hitting the upper end of FCF forecasts. This suggests continued pressure on BA shares and could have ripple effects on key suppliers like GE Aerospace, whose engine fix is crucial. Investors should anticipate continued volatility for BA and potentially re-evaluate aerospace sector growth projections.